OpenAI and its co-founder, Sam Altman, are set to bolster Merge Labs, a burgeoning brain-computer interface startup valued at $850 million and seeking to raise $250 million. This move positions Merge Labs as a direct competitor to Elon Musk's Neuralink. It has been disclosed that the majority of the funding is anticipated to originate from OpenAI's venture capital arm. While Altman was instrumental in Merge Labs' inception, he has not made a direct investment and will not be involved in the company's daily operations. This investment signifies another pivotal technology investment by Altman, extending beyond artificial intelligence, and intensifies his rivalry with Musk in the tech sphere.
